Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03392142
Brief Title: Tabelecleucel for Allogeneic Hematopoietic Cell Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab (MATCH)

First Submitted : December 29, 2017
First Submitted that Met QC Criteria : January 4, 2018
First Posted : January 5, 2018

Last Update Submitted that Met QC Criteria : March 24, 2021
Last Update Posted : March 26, 2021